Sympathetic nervous system and pain: a clinical reappraisal.
The target article discusses various aspects of the relationship between the sympathetic system and pain. To this end, the patients under study are divided into three groups. In the first group, called "reflex sympathetic dystrophy" (RSD), the syndrome can be characterized by a triad of autonomic, motor, and sensory symptoms, which occur in a distally generalized distribution. The pain is typically felt deeply and diffusely, has an orthostatic component, and is suppressed by the ischemia test. Under those circumstances, the pain is likely to respond to sympatholytic interventions. In a second group, called "sympathetically maintained pain" (SMP) syndrome, the principal symptoms are spontaneous pain, which is felt superficially and has no orthostatic component, and allodynia. These symptoms, typically confined to the zone of a lesioned nerve, may also be relieved by sympathetic blocks. Since the characteristics of the pain differ between RSD and SMP, the underlying kind of sympathetic-sensory coupling may also vary between these cases. A very small third group of patients exhibits symptoms of both RSD and SMP. The dependence or independence of pain on sympathetic function reported in most published studies seems to be questionable because the degree of technical success of the block remains uncertain. Therefore, pain should not be reported as sympathetic function independent until the criteria for a complete sympathetic block have been established and satisfied.
Blumberg
H
H
Department of Neurosurgery, University of Freiburg, Germany. boeger@nz11.ukl.uni-freiburg.de
Hoffmann
U
U
Mohadjer
M
M
Scheremet
R
R
D000368:Aged; D001340:Autonomic Nerve Block / Q000379:methods / Q000592:standards; D001831:Body Temperature / Q000502:physiology; D006225:Hand / Q000098:blood supply; D006801:Humans; D007511:Ischemia / Q000150:complications / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D010147:Pain Measurement; D011787:Quality of Health Care; D012019:Reflex Sympathetic Dystrophy / Q000150:complications*; D013565:Sympatholytics / Q000627:therapeutic use
D013565:Sympatholytics